TrialCancer immunology, immunotherapy : CII2026
Bintrafusp alfa for patients with recurrent or metastatic olfactory neuroblastoma.
Nyall R London et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it